Epigallocatechin Gallate (EGCG) as a Protective Agent Against Enzymatic Stromal Degradation in Caprine and Ovine Corneas: Towards Novel Therapeutics for Keratoconus
Muhammad Usman Ali Khan, Syed Tauheed AhmadiD, Sabawoon NisariD, Robina Nematullah KhaniD, Faisal F. KhaniD
Abstract
PurposeKeratoconus (KC) is a progressive corneal ectatic disorder marked by stromal thinning, enzymatic degradation, and oxidative stress. Conventional corneal collagen cross-linking (CXL) therapy poses risks. Epigallocatechin gallate (EGCG), a catechin found in green tea, has been shown to cross-link collagen, inhibit proteases, and modulate inflammation, suggesting its potential as an alternative therapy for KC. This study aimed to (1) evaluate the protective effects of EGCG against collagenase-mediated stromal degradation in caprine and ovine corneas and (2) investigate the use of caprine and ovine cornea as viable ex vivo models for corneal ectasia research. MethodsGoat (n=4) and sheep (n=8) corneoscleral buttons were cultured in an air-liquid interface (ALI). Tissue viability was monitored by transparency grading and histology. The corneal ectasia environment was induced by collagenase type I digestion. An EGCG-rich extract was utilized for the treatments. ResultsGoat and sheep corneas remained intact for 7 days in MEM-based medium, though transparency decreased, with edema (whitening) by Day 7. Histology confirmed stromal loosening and reduced keratocyte cell density but preserved architecture sufficient for enzymatic digestion. EGCG pre-treatment and post-treatment exposure were associated with greater resistance to enzymatic digestion, with greater stromal preservation of quadrants in the EGCG pre-treated quadrant than in PBS pre-treated controls. ConclusionsThis study provides proof of concept that EGCG extract confers protection against enzymatic degradation in goat and sheep corneas, highlighting its potential as a protective agent for corneal ectatic disorders like Keratoconus. Additionally, goat and sheep corneas can represent practical and ethical ex vivo models for short-term ocular research. Future work should focus on cytotoxicity, biomechanical validation, optimized culture conditions, and in vivo studies.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Oxidative-stress related increase in keratoconus tear MDA and GPX3 while NRF2-antioxidant functions decrease in stromal cells
Madhuri Amulya Koduri, Mackenzie E. Charter, … Shukti Chakravarti·bioRxiv·Nov 13, 2025
- Intrastromal graft of anterior lens capsule. A substitute for Bowman layer graft transplantation for keratoconus.
Carlos-Alberto Rodríguez-Barrientos, Amir Translateur, … Carmen Barraquer-Coll·PLoS ONEPeer-reviewed·Nov 19, 2024
- Impact of Rigid Gas Permeable Contact Lenses Removal on Anterior and Posterior Corneal Surfaces in Keratoconus Patients
M. Itoi, K. Kitazawa, … C. Sotozono·bioRxiv·Jul 1, 2019
- A unique and biocompatible approach for corneal collagen crosslinking in vivo
Ayesha Gulzar, Hümeyra Nur Kaleli, … Seda Kızılel·Scientific ReportsPeer-reviewed·Oct 23, 2024
- Ergothioneine: Evaluation of a Novel Antioxidant for Targeting Ocular Oxidative Stress
Rujun He, Wei Ding, … Guohua Xiao·Current Eye ResearchPeer-reviewed·Feb 19, 2026
- A safe and effective method for thin cornea cross-linking
Shengmei Zhou, Zhirong Lin, … Yi Liao·bioRxiv·Jul 3, 2024